TScan Therapeutics, Inc.
TCRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001783328
No open-market purchases or sales by TScan Therapeutics, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $35.1M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in TScan Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- 0 vs. Q1 2023
- Shares held
- 28.0M
- +18.3M (+189.1%) vs. Q1 2023
- Total value
- $69.9M
- +$49.6M (+244.1%) vs. Q1 2023
- New holders
- 5
- 8 more added
- Sold out
- 5
- 4 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $35.1M |
| Q1 2026 | 60 | $32.8M |
| Q4 2025 | 61 | $30.7M |
| Q3 2025 | 73 | $62.9M |
| Q2 2025 | 81 | $51.8M |
| Q1 2025 | 92 | $55.4M |
| Q4 2024 | 89 | $126.2M |
| Q3 2024 | 89 | $208.3M |
| Q2 2024 | 81 | $242.6M |
| Q1 2024 | 66 | $272.3M |
| Q4 2023 | 54 | $186.1M |
| Q3 2023 | 32 | $73.2M |
| Q2 2023 | 28 | $69.9M |
| Q1 2023 | 28 | $20.3M |
| Q4 2022 | 28 | $14.8M |
| Q3 2022 | 26 | $29.0M |
| Q2 2022 | 24 | $30.4M |
| Q1 2022 | 25 | $26.3M |
| Q4 2021 | 29 | $44.4M |
| Q3 2021 | 27 | $83.5M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding TScan Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 5,224,600 | $13.1M | 8.56% | +5,224,600 | New |
| EcoR1 Capital, LLC | 5,000,000 | $12.5M | 0.33% | +5,000,000 | New |
| Adage Capital Partners GP, L.L.C. | 4,000,000 | $10.0M | 0.02% | +3,450,000+627.3% | Added |
| BVF Inc | 2,989,474 | $7.47M | 0.21% | +2,989,474 | New |
| Baker Bros. Advisors LP | 2,784,792 | $6.96M | 0.04% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,359,289 | $3.40M | 0.00% | +1,062,464+357.9% | Added |
| BlackRock Inc. | 1,263,453 | $3.16M | 0.00% | −251,597−16.6% | Reduced |
| Deer Management Co. LLC | 1,245,505 | $3.11M | 0.28% | 00.0% | Unchanged |
| Alphabet Inc. | 1,077,080 | $2.69M | 0.14% | 00.0% | Unchanged |
| Simplify Asset Management Inc. | 1,046,916 | $2.62M | 0.47% | +500,000+91.4% | Added |
| DC Funds, LP | 630,000 | $1.57M | 33.55% | 00.0% | Unchanged |
| Monashee Investment Management LLC | 400,000 | $1.00M | 0.24% | +400,000 | New |
| Tekla Capital Management LLC | 200,000 | $500.0K | 0.02% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 147,462 | $369.0K | 0.00% | +135,862+1,171.2% | Added |
| Geode Capital Management, LLC | 116,891 | $292.2K | 0.00% | +16,449+16.4% | Added |
| Morgan Stanley | 108,475 | $271.2K | 0.00% | −22,844−17.4% | Reduced |
| Stifel Financial Corp | 99,000 | $247.5K | 0.00% | +99,000 | New |
| NewEdge Wealth, LLC | 91,463 | $228.7K | 0.01% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 50,000 | $125.0K | 0.00% | −65,000−56.5% | Reduced |
| State Street Corp | 38,500 | $96.3K | 0.00% | +14,500+60.4% | Added |
| DC Investments Management, LLC | 35,563 | $88.9K | 0.10% | 00.0% | Unchanged |
| Privium Fund Management (UK) Ltd | 15,825 | $40.0K | 0.03% | 00.0% | Unchanged |
| Northern Trust Corp | 15,055 | $37.6K | 0.00% | +905+6.4% | Added |
| Waldron Private Wealth LLC | 10,000 | $25.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,100 | $2.75K | 0.00% | −2,140−66.0% | Reduced |
| Atlas Capital Advisors LLC | 896 | $2.24K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 200 | $500 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 80 | $200 | 0.00% | +5+6.7% | Added |
| Newtyn Management, LLC | 0 | $0 | 0.00% | −236,800−100.0% | Sold out |
| Cannell Capital LLC | 0 | $0 | 0.00% | −14,666−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −4,147−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |